Fig. 4From: A novel nitidine chloride nanoparticle overcomes the stemness of CD133+EPCAM+ Huh7 hepatocellular carcinoma cells for liver cancer therapyTPGS-FA/NC inhibits the AQP3/STAT3/CD133 pathway in Huh7 cells. Huh7 cells were treated with the indicated TPGS-FA/NC concentrations for 48 h. Western blotting was performed to determine the AQP3/STAT3/CD133 signaling-associated protein levelsBack to article page